Literature DB >> 10616870

Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease.

J L Mack1, M B Patterson, P N Tariot.   

Abstract

We studied 555 Alzheimer's disease patients on the Behavior Rating Scale for Dementia (BRSD), which uses informant interviews to measure behavioral pathology in demented patients. For the 45 items, ratings of present ranged from 5% to 66% of the subjects, with 39 rated present in at least 10%. Twenty-nine items were significantly correlated with dementia severity. The mean number of items present per subject was 13.5; only two subjects had none rated present. Factor analysis identified six factors common to mildly and moderately demented subjects. Six subscales were developed: Depressive Symptoms, Inertia, Vegetative Symptoms, Irritability/Aggression, Behavioral Dysregulation, and Psychotic Symptoms. Interitem consistency was high for three subscales (alpha's from .75 to .80) and moderate for three (alpha's from .48 to .56). Four subscale scores and total scores were significantly but weakly correlated with dementia severity. Detailed results and test instructions are presented in the BRSD manual, available from The Consortium to Establish a Registry for Alzheimer's Disease.

Entities:  

Mesh:

Year:  1999        PMID: 10616870     DOI: 10.1177/089198879901200408

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  12 in total

1.  Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Anthony Gamst; Ronald G Thomas; Marian Patterson; Lon S Schneider; Leon J Thal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

2.  Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families.

Authors:  Sandra Barral; Badri N Vardarajan; Dolly Reyes-Dumeyer; Kelley M Faber; Thomas D Bird; Debby Tsuang; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Rafael Lantigua; Martin Z Medrano; Xinbing Wang; M Ilyas Kamboh; Mahmud Muhiedine Barmada; Daniel J Schaid; Tatiana M Foroud; Elise A Weamer; Ruth Ottman; Robert A Sweet; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2015-08-15       Impact factor: 4.673

3.  Instruments to measure behavioural and psychological symptoms of dementia.

Authors:  Rianne M van der Linde; Blossom C M Stephan; Tom Dening; Carol Brayne
Journal:  Int J Methods Psychiatr Res       Date:  2014-02-05       Impact factor: 4.035

4.  Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.

Authors:  Robert A Sweet; David A Bennett; Neill R Graff-Radford; Richard Mayeux
Journal:  Brain       Date:  2010-02-10       Impact factor: 13.501

5.  Qualifying change: a method for defining clinically meaningful outcomes of change score computation.

Authors:  R E Tractenberg; S Jin; M Patterson; L S Schneider; A Gamst; R G Thomas; L J Thal
Journal:  J Am Geriatr Soc       Date:  2000-11       Impact factor: 5.562

6.  Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.

Authors:  Rochelle E Tractenberg; Myron F Weiner; Jeffrey L Cummings; Marian B Patterson; Leon J Thal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

7.  Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Authors:  Gerda G Fillenbaum; Gerald van Belle; John C Morris; Richard C Mohs; Suzanne S Mirra; Patricia C Davis; Pierre N Tariot; Jeremy M Silverman; Christopher M Clark; Kathleen A Welsh-Bohmer; Albert Heyman
Journal:  Alzheimers Dement       Date:  2008-03       Impact factor: 21.566

8.  Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.

Authors:  Patricia A Wilkosz; Chowdari Kodavali; Elise A Weamer; Sachiko Miyahara; Oscar L Lopez; Vishwajit L Nimgaonkar; Steven T DeKosky; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

9.  Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Myron F Weiner; Marian B Patterson; Linda Teri; Leon J Thal
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-06       Impact factor: 2.680

10.  Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.

Authors:  Drew Christie; Jane Shofer; Steven P Millard; Ellen Li; Mary Ann Demichele-Sweet; Elise A Weamer; M Ilyas Kamboh; Oscar L Lopez; Robert A Sweet; Debby Tsuang
Journal:  Behav Brain Funct       Date:  2012-12-27       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.